Opinion

Video

The Role of a Multidisciplinary Team in Managing Kidney Cancer

Clinical insights on the role of a multidisciplinary team in the treatment of kidney cancer and how multidisciplinary care has evolved.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Related Videos
      1 expert in this video
      BPH: The Patient Journey
      Addressing Remaining Unmet Needs in mCRPC
      Addressing Remaining Unmet Needs in mCRPC
      Use and Sequencing of Novel Treatments in NMIBC
      Use and Sequencing of Novel Treatments in NMIBC
      The DORA Trial
      The DORA Trial
      FDA-Approved Treatments for BCG-Unresponsive NMIBC
      FDA-Approved Treatments for BCG-Unresponsive NMIBC
      Cretostimogene Grenadenorepvec and Integration of Novel Therapies in High-Risk BCG-Unresponsive NMIBC
      Cretostimogene Grenadenorepvec and Integration of Novel Therapies in High-Risk BCG-Unresponsive NMIBC
      Clinical Perspectives on Early Use of RAD-ENZ
      Clinical Perspectives on Early Use of RAD-ENZ
      Treatment Selection for mCRPC
      Treatment Selection for mCRPC
      Other Investigational Drug Delivery Systems in NMIBC
      Other Investigational Drug Delivery Systems in NMIBC
      Medcast series
      Episode 3 Video: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges
      Related Content
      US FDA logo in white over a blue background. | Credit: US Food and Drug Administration
      February 4th 2025

      FDA Updates in Urology: January 2025

      Patrick Campbell
      A recap of the FDA submissions and regulatory decisions in urology from January 2025.
      Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges
      January 14th 2025

      Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges

      Wayne Kuang, MD Steven Maislos, MD
      Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.
      doctor holding a pen talking to patient
      December 14th 2022

      Study finds only half of patients undergoing 24-hour urine tests receive complete testing

      Hannah Clarke
      “One of the goals of this study was to look at whether 24-hour urine testing in the VA population included all the important components of 24-hour urine panel testing,” says Ryan Hsi, MD, FACS.
      Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults
      November 27th 2024

      Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

      Wayne Kuang, MD Bilal Chughtai, MD
      Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.
      Doctor discusses treatment information with patient
      October 19th 2022

      Study finds inadequate patient education for scheduled urologic procedures

      Hannah Clarke
      Researchers at Albert Einstein College of Medicine found patients benefited from a pre-procedural interview to educate them about the risks, benefits, and alternatives to urologic treatments they were scheduled to receive.
      UroView: The Role of Liquid Biomarkers for Early Detection of Prostate Cancer
      July 19th 2021

      UroView: The Role of Liquid Biomarkers for Early Detection of Prostate Cancer

      David Albala, MD Judd W. Moul, MD
      This article features insights from David Albala, MD, and Judd W. Moul, MD, on using liquid biomarker-based testing for the early detection of prostate cancer.
      © 2025 MJH Life Sciences

      All rights reserved.